South Korea-based ExoCoBio Inc, a exosome regenerative aesthetics company, has raised $9.3 million in funding. The company’s investors include K2 Investment Partners, SBI Investment Korea, Dt & Investment, G.N.Tech/ReeHu Investment and Focus Assets Management.
Source: Press Release
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: